Anpario plc (AIM: ANP)

Market Cap	73.13M
Revenue (ttm)	32.72M
Net Income (ttm)	3.02M
Shares Out	20.31M
EPS (ttm)	0.18
PE Ratio	20.03
Forward PE	16.72
Dividend	0.11 (2.99%)
Ex-Dividend Date	Nov 14, 2024

Volume	37,214
Open	361.27
Previous Close	360.00
Day's Range	352.00 - 363.50
52-Week Range	220.00 - 394.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 109
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2023, Anpario's revenue was 31.00 million, a decrease of -6.36% compared to the previous year's 33.10 million. Earnings were 2.53 million, a decrease of -23.46%.